Holen Sie sich die Stockscreener-App
5.69
1.56%
-0.09
Handel nachbörslich:
5.90
0.21
+3.69%
Schlusskurs vom Vortag:
$5.78
Offen:
$5.865
24-Stunden-Volumen:
64,770
Relative Volume:
1.07
Marktkapitalisierung:
$95.17M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.88M
KGV:
-5.8061
EPS:
-0.98
Netto-Cashflow:
$-10.29M
1W Leistung:
-5.95%
1M Leistung:
+3.36%
6M Leistung:
+0.53%
1J Leistung:
-23.62%
1-Tages-Spanne:
$5.66
$5.8966
1-Wochen-Bereich:
$5.66
$6.199
52-Wochen-Spanne:
$4.65
$10.24
Coya Therapeutics Inc Stock (COYA) Company Profile
Firmenname
Coya Therapeutics Inc
Sektor
Branche
Telefon
650.739.3939
Adresse
12645 MEMORIAL DR., SUITE F1 #305, HOUSTON
Vergleichen Sie COYA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COYA
Coya Therapeutics Inc
|
5.69 | 101.19M | 0 | -14.88M | -10.29M | -0.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Coya Therapeutics Inc Stock (COYA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-09 | Eingeleitet | Lake Street | Buy |
| 2024-12-04 | Eingeleitet | D. Boral Capital | Buy |
Coya Therapeutics Inc Aktie (COYA) Neueste Nachrichten
What analysts say about Coya Therapeutics Inc. stockRapid wealth accumulation - jammulinksnews.com
Coya Therapeutics Inc. Stock Analysis and ForecastBreakout stock performance - jammulinksnews.com
What drives Coya Therapeutics Inc. stock priceDynamic investment growth - jammulinksnews.com
Is Coya Therapeutics Inc. a good long term investmentFree Wealth Management Insights - jammulinksnews.com
Why Coya Therapeutics Inc. stock attracts strong analyst attentionMomentum Swing Watchlist - Newser
Coya Therapeutics shares rise 4.67% premarket after announcing participation in the BTIG Virtual Biotechnology Conference. - AInvest
Coya Therapeutics to Participate in BTIG Virtual Biotechnology Conference - AInvest
Coya Therapeutics to Participate in the BTIG Virtual Biotechnology Conference July 29 – 30, 2025 - Business Wire
(COYA) Investment Report - news.stocktradersdaily.com
What drives BENFW stock priceConsistent double returns - jammulinksnews.com
What makes Coya Therapeutics Inc. stock price move sharplyLow Risk Trade Timing Signals - Newser
How Coya Therapeutics Inc. stock performs during market volatilityFree Stock Selection with 300% Return - Newser
Coya Therapeutics (NASDAQ:COYA) Coverage Initiated at Lake Street Capital - Defense World
Coya Therapeutics initiated with a Buy at Lake Street - TipRanks
Coya Therapeutics stock initiated with Buy rating at Lake Street Capital - Investing.com UK
With CAR Ts and islets raising the bar in I&I, what’s the play for Tregs? - biocentury.com
Positive Outlook for Coya Therapeutics, Inc. Driven by IND Resubmission and Promising Trial Results - TipRanks
Coya Therapeutics (COYA) Receives Continued Buy Rating from Analyst | COYA Stock News - GuruFocus
Coya Therapeutics resubmits IND application for ALS Phase 2 study to FDA - Investing.com
Coya Therapeutics Holds Annual Stockholders Meeting - TipRanks
After myriad failures, a new wave of ALS drugs approaches - Pharma Voice
Coya Therapeutics to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24 – 25, 2025 - Business Wire
Trading (COYA) With Integrated Risk Controls - news.stocktradersdaily.com
Coya Therapeutics (NASDAQ:COYA) Receives Buy Rating from HC Wainwright - Defense World
Coya Therapeutics (COYA) Receives Confirmed Buy Rating from HC W - GuruFocus
Coya Therapeutics (COYA) Receives Confirmed Buy Rating from HC Wainwright | COYA Stock News - GuruFocus
Coya Therapeutics (COYA) Rated Buy by Analyst with $20 Target | COYA Stock News - GuruFocus
Finanzdaten der Coya Therapeutics Inc-Aktie (COYA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):